NET PROFIT (x1000 NOK)
EMPLOYEES
Jemo-Pharm A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-682
|
-1,492
|
384 |
| Total assets |
64,295
|
59,773
|
55,060 |
| Current assets |
44,607
|
42,010
|
37,201 |
| Current liabilities |
63,336
|
52,532
|
48,620 |
| Equity capital |
-241
|
-515
|
759 |
| - share capital |
603
|
566
|
536 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-0.4%
|
-0.9%
|
1.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
70.4%
|
80.0%
|
76.5% |
| Return on equity (ROE) |
283.0%
|
289.7%
|
50.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.